IOL Chemicals & Pharmaceuticals Share Price Today

IOL Chemicals secures EDQM certificate for Fenofibrate Process II

IOL Chemicals obtained EDQM Certificate of Suitability for Fenofibrate - Process II. Certification granted on September 24, 2026, adding to existing Fenofibrate CEP. Enables supply to regulated markets including Europe. Process II developed to meet specific customer requirements.

IOL Chemicals secures EU-REACH registration for Triacetin exports

IOL Chemicals secured EU-REACH registration for Triacetin. Certification enables exports to all European Union countries. Approval granted by European Chemicals Agency under REACH framework. Registration supports expanded global market access and compliance.

IOL Chemicals to host virtual investor meet with Nuvama PCG on Sept 28

IOL Chemicals will host a virtual investor meet on September 28, 2026. The event is organized by Nuvama PCG as a group meeting. Discussions are limited to public information and past results. No unpublished price-sensitive information will be disclosed.

IOL Chemicals releases transcript of September 11 business update call

IOL Chemicals releases full transcript of Sept 11, 2026 business update call. Details ₹500 crore investment in Ibuprofen, CDMO, and specialty chemical facilities. Initiatives expected to add 25-30% to top line upon full operationalization. Funding sourced from internal accruals with 30% already incurred.

IOL Chemicals plans ₹495 crore expansion for ibuprofen, CDMO units

IOL Chemicals announces ₹495 crore expansion plan funded via internal accruals. New 6,000 MTPA ibuprofen plant to raise total capacity to 18,000 MTPA by Dec 2027. ₹110 crore CDMO facility for pharma formulations targets European anchor customers. Dedicated specialty chemicals unit set up under long-term tolling arrangement. Both new facilities expected to commercialize in Q3 FY27.

IOL Chemicals shareholders approve FY26 financials, reappoint director

Shareholders approved adoption of FY26 standalone and consolidated audited financial statements. Kushal Kumar Rana was reappointed as director after retiring by rotation. Cost auditor remuneration for FY27 was ratified by shareholders. 92 shareholders attended the virtual AGM, including five promoters and 87 public investors.